Casamento Charles J

Casamento Charles J is listed in filings as Director at Relmada Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 14, 2026, including 3 public disclosures. Recent filings connect the profile to Relmada Therapeutics, Inc. (RLMD) and Eton Pharmaceuticals, Inc. (ETON). The current snapshot covers public activity from Dec 16, 2025 to Jan 14, 2026. Reported amounts are shown as $665.8K to $188.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.